Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The ODYSSEY OUTCOMES Committees and Investigators
Research output: Contribution to journal › Article › peer-review
283Scopus
citations
Fingerprint
Dive into the research topics of 'Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial'. Together they form a unique fingerprint.